Role of dermatocosmetics and accompanying care in patients with psoriasis
https://doi.org/10.33667/2078-5631-2021-34-18-22
Abstract
Dermatocosmetics plays an important role in psoriasis and is used in various dosage forms, depending on the localization of the process and with various active molecules that provide keratolytic, anti-inflammatory and moisturizing effects. Pierre Fabre company has developed the Kertyol P. S.O. (shampoo and concentrate for topical use), which provides additional skin care for psoriasis.
Material and methods. 28 patients with psoriasis vulgaris with localization of the process on smooth skin and scalp were under observation. In all patients, the process corresponded to mild severity (PASI < 10 points). On smooth skin, patients used calcipotriol (one time per day) and Kertyol P. S.O. The drug was applied twice a day (morning and evening) to psoriatic plaques on the body for 4 weeks. Shampoo Kertyol P. S.O. was used 3 times a week for 4 weeks in conjunction with a local drug (hydrocortisone one time per day). Research results. Against the background of therapy with localization on smooth skin, after one week, there was a positive trend in relation to peeling, infiltration and erythema: the PASI index decreased by 13.0 %, in 4 weeks by 67.2 %. When localized on the scalp after a week, the PASI index decreased by 21.4 %, to the end of the observation period by 80.9 %. After 4 weeks of therapy, with localization on smooth skin, the VAS decreased by 77.2 % points, with localization on the scalp by 73.1 %. In general, for the group, DIKZH improved by 73.7 %. All the patients noted good organoleptic properties of dermatocosmetics, ease of use.
Conclusion. Kertyol P. S.O. can be recommended as an adjuvant therapy for psoriasis of smooth skin and scalp.
About the Authors
L. S. KruglovaRussian Federation
Kruglova Larisa S., DM Sci (habil.), professor, head of Dept of Dermatovenereology and Cosmetology
Moscow
N. S. Rudneva
Russian Federation
Rudneva Natalia S., PhD Med, chief freelance specialist – dermatovenerologist, cosmetologist of the Ministry of Health of the Tula Region, chief physician, associate professor at Dept of Propedeutics of Internal Diseases, course of Dermatovenerology
Tula
References
1. Kruglova L. S., Ponich E. S., Levshin R. N. Barrier function of the skin: the main causes of disorders and methods of correction. South Ural Medical Journal. 2015. No. 2. P. 37–44.
2. Kruglova L. S. Medical cosmetics as a factor that increases patient adherence to acne therapy. Clinical Dermatology and Venereology. 2014. No. 5. P. 75–83.
3. Kruglova L. S., Zhukova O. V. Additive acne therapy. Clinical Dermatology and Venereology. 2016. No. 1. P. 39–47.
4. Acne and rosacea. Edited by L. S. Kruglova GEOTAR-Media. 2021. 207 p.
5. Kruglova L. S., Gensler E. M. Atopic dermatitis: new horizons of therapy. Medical Alphabet. Dermatology. 2019. No. 7 (382), V. 1. P. 29–32.
6. Potekaev N. N., Kruglova L. S. Psoriatic disease. Moscow. DVA. 2014. 264 p.
7. Kruglova L. S., Petriy M. A., Gensler E. M. Evaluation of the effectiveness of the use of activated zinc pyrithione in the treatment of patients with psoriasis. Clinical Dermatology and Venereology. 2019, 18 (5): 616–623.
8. Wang Y, Lin Z, Zhang B, Jiang Z, Guo F, Yang T. Cichorium intybus L. Extract Suppresses Experimental Gout by Inhibiting the NF-κB and NLRP3 Signaling Pathways. Int J Mol Sci. 2019 Oct 4; 20 (19): 4921.
9. Thouvenin MD, Dalmon S, Theunis J, Lauze C, Coubetergues H, Mengeaud V, Calvet B. Tolerance and efficacy of a new celastrol-containing balm as adjunct care in psoriasis. J Eur Acad Dermatol Venereol. 2020 Aug; 34 Suppl 6: 10–16.
Review
For citations:
Kruglova L.S., Rudneva N.S. Role of dermatocosmetics and accompanying care in patients with psoriasis. Medical alphabet. 2021;(34):18-22. (In Russ.) https://doi.org/10.33667/2078-5631-2021-34-18-22